DRUGBright Minds Biosciences Inc
DRUG
Bright Minds Biosciences Inc7,616
Mkt Cap
$655.48MVolume
115,048.0052W High
$93.4052W Low
$23.18PE Ratio
-88.95DRUG Fundamentals
Price
$85.67Prev Close
$84.19Open
$85.1550D MA
$63.33Beta
0.96Avg. Volume
172,226.47EPS (Annual)
-$0.4777P/B
15.70Bright Minds Biosciences (NASDAQ:DRUG) Sets New 52-Week High - Still a Buy?
Bright Minds Biosciences (NASDAQ:DRUG) Sets New 52-Week High - Still a Buy...
MarketBeat·4d ago
Bright Minds Biosciences (NASDAQ:DRUG) Hits New 1-Year High - Time to Buy?
Bright Minds Biosciences (NASDAQ:DRUG) Sets New 1-Year High - Should You Buy...
MarketBeat·4d ago
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 10.3% - Time to Buy?
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 10.3% - Still a Buy...
MarketBeat·5d ago
Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 1-Year High - Here's Why
Bright Minds Biosciences (NASDAQ:DRUG) Sets New 52-Week High - Still a Buy...
MarketBeat·9d ago
Bright Minds Biosciences (NASDAQ:DRUG) Sees Unusually-High Trading Volume - Should You Buy?
Bright Minds Biosciences (NASDAQ:DRUG) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat·11d ago
Cantor Fitzgerald Analysts Lower Earnings Estimates for DRUG
Bright Minds Biosciences Inc. (NASDAQ:DRUG - Free Report) - Investment analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Bright Minds Biosciences in a research report issued...
MarketBeat·11d ago
Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 1-Year High - Time to Buy?
Bright Minds Biosciences (NASDAQ:DRUG) Hits New 52-Week High - Still a Buy...
MarketBeat·16d ago
Recent Price Trend in Bright Minds Biosciences Inc. (DRUG) is Your Friend, Here's Why
Bright Minds Biosciences Inc. (DRUG) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks·19d ago
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 36.3% in Bright Minds Biosciences Inc. (DRUG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·20d ago
FY2025 Earnings Forecast for DRUG Issued By Chardan Capital
Bright Minds Biosciences Inc. (NASDAQ:DRUG - Free Report) - Equities researchers at Chardan Capital issued their FY2025 earnings estimates for Bright Minds Biosciences in a research report issued on...
MarketBeat·22d ago
<
1
2
...
>